ReadyRx GLP‑1 Review: Is It Legit?

ReadyRx is run by Ready Health Ventures Inc., which owns readyrx.com and getreadyrx.com. Its terms give a mailing address in Wilmington, Delaware, and are governed by Tennessee law. The site prints no phone number.

It is not a medical practice or a pharmacy. The terms say ReadyRx "is not a healthcare provider" and that care comes from third-party "Medical Groups" whose providers prescribe through the platform. They name no medical group. The site says every plan is "reviewed and guided by licensed, board-certified clinicians".

Here is how it goes. You fill in an online assessment, which ReadyRx says takes 2 minutes. A clinician reviews it. If you are approved, you are billed for the plan you chose, and the medication ships to your door.

ReadyRx sells compounded semaglutide and tirzepatide as weekly injections, brand-name Ozempic and Zepbound, metformin, sermorelin, NAD+, glutathione and MIC+B12. Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved; the safety section explains what that means. To read about the drugs themselves, see our pages on semaglutide and tirzepatide.

ReadyRx sells sermorelin as an injection or a tablet that dissolves in the mouth (ODT), and NAD+ as an injection or a nasal spray. As of October 24, 2026, with the site-wide code applied, sermorelin is $190 a month month to month and NAD+ is $160; without the code, they are $225 and $190. This review covers ReadyRx's GLP-1 program only. We have not scored its sermorelin or NAD+ treatments, and its Trustpilot rating covers every product it sells.

As of October 24, 2026, ReadyRx is an operating company with no FDA warning letter on file. It is run by Ready Health Ventures Inc. and has 4.7 on Trustpilot from about 1,150 reviews. Two gaps stand out: it names no pharmacy, and it names no clinician or medical group.

ReadyRx and Ready Med are different companies. The FDA warning letter of June 8, 2026 went to "Ready Med", a weight-loss service in Clearwater, Florida, whose website is readymednow.com. ReadyRx is Ready Health Ventures Inc., which runs readyrx.com and getreadyrx.com and gives a mailing address in Wilmington, Delaware. The letter does not name ReadyRx, and we found no shared owner, address, website, phone number or email between the two.

ReadyRx does not name its pharmacies, and that is the bigger of the two gaps. It says "all medications are sourced through FDA-registered, U.S.-based compounding pharmacies", but it does not say whether they are 503A or 503B. Its terms add that prescriptions "may also be transferred among the Pharmacies without notice." So there is no pharmacy to check against the FDA's records.

As of October 24, 2026, compounded semaglutide costs $159 a month month to month, or $109 a month on the quarterly plan. Compounded tirzepatide costs $185 a month, or $145 a month on the quarterly plan. The price is the same at every dose.

The quarterly plan is paid up front: "*Price shown applies to quarterly plans paid up-front." That is $327 every three months for semaglutide and $435 for tirzepatide.

Those prices include the discount. ReadyRx's banner reads "LIMITED TIME DEAL: Extra $90 Off - Code: GETHEALTHY26", and its pages show the list price struck through: $249 a month for semaglutide and $315 for tirzepatide. The pricing table shows "$159/first month" and "$159/mo. after". The product headers call the same price "/first mo.". Check the price for later months at checkout before you pay.

The fees are simple. There is no membership or visit fee, shipping is free, and messaging with a physician is included. ReadyRx doesn't take insurance; its GLP-1 page says the treatment is "HSA/FSA Eligible".

Brand-name pens cost far more. Ozempic is $1,289 a month and Zepbound $1,385 a month through ReadyRx.

ReadyRx's care is online. A clinician from one of the medical groups ReadyRx works with reviews your assessment and decides whether a GLP-1 fits you. ReadyRx does not state how long the review takes.

After that, the plan renews on its own. "Refills are processed automatically to ensure you never run out," and the terms allow a renewal to be charged and shipped "up to three(3) days early". The pages promise "unlimited physician messaging", meal plans and coaching.

ReadyRx does not publish which states it serves. Its terms say the service is open to people "located in states in which we offer the Service".

ReadyRx has no FDA warning letter on file. The June 2026 letter to Ready Med concerns readymednow.com, a Florida business that is not ReadyRx.

The pharmacy can't be checked. ReadyRx names no pharmacy, so we can't match its pharmacies against the FDA's letters, inspections or outsourcing register.

Two things on ReadyRx's own pages are worth knowing. Its GLP-1 pages picture vials labelled "ReadyRx" beside Ozempic and Zepbound pens, although ReadyRx says it "does not store, compound, furnish, sell, or dispense" prescription drugs. The FDA objected to vial labels carrying the seller's name in its letter to Ready Med. And on its semaglutide and tirzepatide pages, the card that sells compounded tirzepatide calls it "The latest FDA-approved GLP-1 for effective fat reduction and appetite control". Compounded tirzepatide is not FDA-approved, and the same pages say so lower down.

The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12. Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.

You can cancel ReadyRx at any time, and it takes effect at the end of the period you paid for. Cancel at least 4 business days before your renewal date, or the next period is charged. The terms give two ways: one section says to email support@readyrx.com, another that cancellations must be completed "through the customer dashboard". Use the dashboard and keep the confirmation.

The refund rule is strict. The terms say "ALL SALES ARE FINAL": no refund once an order is processed, shipped or delivered, and none for a partly used period. Refunds beyond that are at ReadyRx's "sole and absolute discretion". Billing errors have to be reported within 5 business days of delivery.

The quarterly plan is paid up front and renews every three months until you cancel. Only choose it if you expect to stay on the medication for three months. If you have side effects, talk to your provider.

ReadyRx also has a weight-loss guarantee, with strict conditions. It refunds the program fees of the first seven months if you lose less than 5% of your starting weight after 28 straight weeks. You must be new to weight-loss medication for the past 12 months, log your progress every week, reach at least a set dose, and prove your weight with a doctor's attestation or a scale video. ReadyRx decides "at the sole discretion of the Company".

As of October 24, 2026, ReadyRx has a 4.7 TrustScore on Trustpilot from about 1,150 reviews, and 87% of them are five stars. ReadyRx invites customers to review it, and almost all of the reviews are from the last 12 months. The good reviews praise the staff, follow-up calls and fast shipping.

The one-star reviews are 6% of the total. We read the 20 most recent, posted from June to October 2026, and a review can raise more than one problem. About 9 describe a cancellation that was not honoured and further charges, about 7 a shipment that arrived warm, late or at the wrong address, and about 6 a refund refused or only partly paid. Others describe slow customer service, a charge with no shipment, and a wrong dose or missing syringes. ReadyRx replied to 17 of the 20, and to 93% of its negative reviews overall.

We found no Better Business Bureau profile for ReadyRx or Ready Health Ventures. The patient stories on ReadyRx's pages are marketing, not results you can expect. This site collects no independent reviews of its own yet.

Our score combines seven checks. Each one counts for a fixed share of the total, listed below. Commission is not an input.

• Price transparency: 9.7/10 (counts for 20% of the total score). Every GLP-1 price and plan is on a public page, with no membership or visit fee. Note that every price rests on a "limited time" discount, and the pages label it both "/first mo." and "/mo. after" without saying how long it lasts.
• Cost and value: 8/10 (counts for 15% of the total score). We compare month-to-month prices: $159 for semaglutide ranks 5 of 17 programs that sell both compounded and brand-name drugs, against a median of $199.99.
• Medication and pharmacy traceability: 4.6/10 (counts for 15% of the total score). No pharmacy named, no pharmacy type stated, and prescriptions can move between pharmacies without notice.
• Clinical access and oversight: 8.3/10 (counts for 15% of the total score). Licensed, board-certified clinicians and included physician messaging, but no clinician or medical group named and no stated review time.
• Safety and enforcement: 8.3/10 (counts for 20% of the total score). No FDA warning letter on file. We take half a point off for the vial images labelled "ReadyRx" and the card calling compounded tirzepatide "FDA-approved", the kind of claims the FDA has cited in letters to other programs.
• Terms, commitment and refunds: 9/10 (counts for 10% of the total score). No minimum term and no cancellation fee. We take a point off because all sales are final, the terms give two different ways to cancel, and one-star reviews often describe a cancellation that was not honoured.
• Availability and fulfilment: 8.3/10 (counts for 5% of the total score). Free shipping, but no published list of the states it serves.

This is the first score for ReadyRx. Confidence is medium: our October 24 re-read found the same month-to-month prices we track, but we read fewer of its pages than we need for high confidence. Two of the seven checks carry an editor's adjustment, explained above; together they lower the total by 0.2. The method is on our methodology page.